Eiko LifeSciences Past Earnings Performance
Past criteria checks 4/6
Eiko LifeSciences has been growing earnings at an average annual rate of 56%, while the Chemicals industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 25.5% per year. Eiko LifeSciences's return on equity is 2.3%, and it has net margins of 3.5%.
Key information
56.0%
Earnings growth rate
56.8%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 25.5% |
| Return on equity | 2.3% |
| Net Margin | 3.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Eiko LifeSciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 339 | 12 | 3 | 0 |
| 30 Jun 24 | 322 | 10 | 6 | 0 |
| 31 Mar 24 | 279 | 8 | 3 | 0 |
| 31 Dec 23 | 261 | 7 | 3 | 0 |
| 30 Sep 23 | 239 | 7 | 3 | 0 |
| 30 Jun 23 | 218 | 8 | 3 | 0 |
| 31 Mar 23 | 183 | 8 | 4 | 0 |
| 31 Dec 22 | 170 | 6 | 3 | 0 |
| 30 Jun 22 | 200 | 4 | 3 | 0 |
| 31 Mar 22 | 254 | 7 | 3 | 0 |
| 31 Dec 21 | 263 | 9 | 3 | 0 |
| 30 Jun 21 | 197 | 10 | 2 | 0 |
| 31 Mar 21 | 120 | 6 | 1 | 0 |
| 31 Dec 20 | 64 | -1 | 2 | 0 |
| 30 Sep 20 | 52 | -10 | 1 | 0 |
| 30 Jun 20 | 88 | -17 | 1 | 0 |
| 31 Mar 20 | 104 | -19 | 1 | 0 |
| 31 Dec 19 | 108 | -17 | 0 | 0 |
| 30 Sep 19 | 85 | -12 | 0 | 0 |
| 30 Jun 19 | 54 | -5 | 0 | 0 |
| 31 Mar 19 | 43 | -4 | 0 | 0 |
| 31 Dec 18 | 54 | -2 | 0 | 0 |
| 30 Sep 18 | 46 | -1 | 0 | 0 |
| 30 Jun 18 | 35 | 1 | 0 | 0 |
| 31 Mar 18 | 24 | 2 | 0 | 0 |
| 31 Dec 17 | 5 | 2 | 0 | 0 |
| 30 Sep 17 | 5 | 2 | 0 | 0 |
| 30 Jun 17 | 5 | 2 | 0 | 0 |
| 31 Mar 17 | 4 | 2 | 0 | 0 |
| 31 Dec 16 | 6 | 1 | 0 | 0 |
| 30 Sep 16 | 5 | 1 | 0 | 0 |
| 30 Jun 16 | 6 | 1 | 0 | 0 |
| 31 Mar 16 | 6 | 1 | 0 | 0 |
| 31 Dec 15 | 3 | 1 | 0 | 0 |
| 30 Sep 15 | 2 | 1 | 0 | 0 |
| 30 Jun 15 | 2 | 0 | 0 | 0 |
| 31 Mar 15 | 1 | 0 | 0 | 0 |
| 31 Dec 14 | 1 | 0 | 0 | 0 |
| 30 Sep 14 | 1 | 0 | 0 | 0 |
| 30 Jun 14 | 1 | 0 | 0 | 0 |
| 31 Mar 14 | 1 | 0 | 0 | 0 |
| 31 Dec 13 | 2 | 0 | 0 | 0 |
Quality Earnings: 540204 has a high level of non-cash earnings.
Growing Profit Margin: 540204's current net profit margins (3.5%) are higher than last year (3.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 540204 has become profitable over the past 5 years, growing earnings by 56% per year.
Accelerating Growth: 540204's earnings growth over the past year (63.1%) exceeds its 5-year average (56% per year).
Earnings vs Industry: 540204 earnings growth over the past year (63.1%) exceeded the Chemicals industry 7.3%.
Return on Equity
High ROE: 540204's Return on Equity (2.3%) is considered low.